Standout Papers
Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Fibrinogen: a possible link between social class and coronary heart disease.
1985
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Ross operation in children and young adults: the Alder Hey case series
2004
Heparin-Protein Interactions
2002 Standout
Autograft and pulmonary allograft performance in the second post-operative decade after the Ross procedure: insights from the Rotterdam Prospective Cohort Study
2012
INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
2004 StandoutNobel
Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation
2004
Recent Insights into the Pathogenesis of Pre-eclampsia
2002
The international normalized ratio calibrated for cirrhosis (INRliver) normalizes prothrombin time results for model for end‐stage liver disease calculation†
2007
Has the Quick or the Owren prothrombin time method the advantage in harmonization for the International Normalized Ratio system?
2002
Fourteen-year experience with homovital homografts for aortic valve replacement
1995
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
A Reversible Posterior Leukoencephalopathy Syndrome
1996 Standout
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Hemodynamic and clinical impact of prosthesis–patient mismatch in the aortic valve position and its prevention
2000
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Guillain-Barré syndrome
2016 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Exercise Standards for Testing and Training
2013 Standout
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The molecular basis of blood coagulation
1988 Standout
Reoperations on the pulmonary autograft and pulmonary homograft after the Ross procedure: An update on the German Dutch Ross Registry
2012
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Changes in International Normalized Ratio (INR) and Model for Endstage Liver Disease (MELD) Based on Selection of Clinical Laboratory
2007
Population modelling of the effect of inogatran, at thrombin inhibitor, on ex vivo coagulation time (APTT) in healthy subjects and patients with coronary artery disease
2001
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Right Ventricular Outflow Tract Reconstruction in Ross Patients: Does the Homograft Fare Better?
2008
Angiogenic imbalance in the pathophysiology of preeclampsia: Newer insights
2004
Pre-eclampsia
2005 Standout
Respiratory health consequences of environmental tobacco smoke
2004
A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology†
2007
Protective and Damaging Effects of Stress Mediators
1998 Standout
The Antiphospholipid Syndrome
2002 Standout
Should we Include Anti-prothrombin Antibodies in the Screening for the Antiphospholipid Syndrome?
2000
Diabetes and Atherosclerosis
2002 Standout
The Ross operation: a 12-year experience
1999
Purification and characterization of an antithrombin III inactivating enzyme from the venom of the African night adder (Causus rhombeatus)
1992
Long-term performance of heart valve prostheses
2000
Renal Vascular and Thrombotic Effects of Cyclosporine
1989
Pre-eclampsia
2010 Standout
Burden of valvular heart diseases: a population-based study
2006 Standout
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
1991 Standout
Disseminated Intravascular Coagulation
1999 Standout
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
Recurrent miscarriage
2006 Standout
Homograft replacement of the mitral valve
1996
Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: A randomized trial in patients with mechanical prosthetic heart valves
1997
Pre-eclampsia
2015 Standout
The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits
1982
Association of Hormone Replacement Therapy With Hemostatic and Other Cardiovascular Risk Factors
1995
Familial Thrombosis Due to Antithrombin III Deficiency
1974
Questions and Answers on Prothrombin Time Standardisation in Oral Anticoagulant Control
1985
Serpin Structure, Mechanism, and Function
2002 Standout
Epsilon‐Aminocaproic Acid Therapy for Dental Extractions in Haemophilia and Christmas Disease: A Double Blind Controlled Trial
1971
1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASE
1977 Standout
Immunologic Studies in von Willebrand's Disease
1972
Low-affinity heparin potentiates the action of high-affinity heparin oligosaccharides
1984
The presence and reactions of high and lower-molecular-weight procoagulant factor VIII in the plasma of patients with von Willebrand's disease after treatment: Significance for a structural hypothesis for factor VIII
1973
Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's disease
1971
Anticoagulant Action of Heparin
1973 Nature
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Detection of Heterozygotes for Recessive von Willebrand's Disease by the Assay of Antihemophilic-Factor-like Antigen
1973
Platelet Function
1969
Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.
1987
Redefining Preeclampsia Using Placenta-Derived Biomarkers
2013
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Amyloid Deposits and Amyloidosis
1980 Standout
Alterations in the blood clotting system in disseminated intravascular coagulation
1967
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
HÆMOSTATIC, LIPID, AND BLOOD-PRESSURE PROFILES OF WOMEN ON ORAL CONTRACEPTIVES CONTAINING 50 µg OR 30 µg ŒSTROGEN
1977
The Defect in Hemophilic and von Willebrand's Disease Plasmas Studied by a Recombination Technique
1974
Syndrome of Acquired Factor X Deficiency and Systemic Amyloidosis
1977
Partial NH2- and cooh-terminal sequence analyses of Eco RI DNA restriction and modification enzymes.
1981 StandoutNobel
The factor IX phospholipid-binding site is required for calcium-dependent activation of factor IX by factor XIa.
1987
Actions of Thrombin and Other Coagulant and Proteolytic Enzymes on Blood Platelets
1967 Nature
Platelet Coagulant Activities and Hemostasis: A Hypothesis
1974
Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
1982 Standout
HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY
1986 Standout
An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
1976 StandoutNatureNobel
Association between dietary fat intake and plasma factor VII coagulant activity — A predictor of cardiovascular mortality
1986
The isolation and purification of a bovine-plasma protein which is a substrate for the coagulant fraction of Russell's-viper venom
1962
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Disseminated intravascular coagulation. Findings in 346 patients.
1980 Standout
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
The Role of Platelets in the Contact Phase of Blood Coagulation
1972
Solid‐Phase Immunoradiometric Assay of Factor‐VIII Protein
1975
In Preeclampsia, the Circulating Factors Capable of Altering In Vitro Endothelial Function Precede Clinical Disease
2005
Low-Molecular-Weight Heparins
1997 Standout
Immunological Characterization of Purified Anti-Haemophilic Factor A (Factor VIII) which corrects Abnormal Platelet Retention in Von Willebrand's Disease
1972
The Obstetric Patient and Disseminated Intravascular Coagulation
1986
A catalytic role for heparin
1978
Development of Large Scale Fractionation Methods
1979
Reduced tissue factor (thromboplastin) activity in von Willebrand's disease
1974
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Two Recombinant Tissue Factor Reagents Compared to Conventional Thromboplastins for Determination of International Normalised Ratio: A Thirty-three-laboratory Collaborative Study
1996
Studies on Phospholipids in the Action of a Lupus Coagulation Inhibitor
1975
Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time
2010 StandoutNobel
The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor
1973 Standout
Platelet Function and Coagulation Profile in Lupus Erythematosus
1974
The molecular-weight-dependence of the anti-coagulant activity of heparin
1978
Haemostasis in Normal Pregnancy
1984
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
1990 Standout
Human antithrombin III. Carbohydrate components and associated glycolipid.
1978
Platelet Physiology and Abnormalities of Platelet Function
1975 Standout
Relationships of Ca++ to “Protein-bound” Phosphate Fractions of Mitochondria
1965 StandoutNobel
The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis
1967
Works of K. W. E. Denson being referenced
An attempt to standardize the APTT for heparin monitoring, using the P.T. ISI/INR system of calibration. Results of a 13 centre study
1994
Comparative Studies of Rabbit and Human Recombinant Tissue Factor Reagents
1999
Passive smoking in infants, children and adolescents. The effects of diet and socioeconomic factors
2001
Thromboplastin-sensitivity, precision and other characteristics
1988
Electrophoretic Studies of the Prower Factor; a Blood Coagulation Factor which differs from Factor VII
1958
The Measurement of Heparin
1973
Two Types of Haemophilia (A+ and A−): A Study of 48 Cases
1969
The Mode of Action of Antibodies which Destroy Factor VIII
1972
The ratio of factor VIII-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting
1977
The Mode of Action of a Coagulation Inhibitor in the Blood of Two Patients with Disseminated Lupus Erythematosus (DLE)
1964
SUBCUTANEOUS HEPARIN
1974
A Study of the Coagulant Action of Eight Snake Venoms
1964
Standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
1967
The Coagulant Activity of Platelets
1968
The Specific Assay of Prower-Stuart Factor and Factor VII
1961
The Preparation for Therapeutic Use of a Concentrate of Factor IX Containing also Factors II, VII and X
1967
ANTIGEN/BIOLOGICAL-ACTIVITY RATIO FOR FACTOR VIII
1973
Multicenter Evaluation of Lyophilized and Deep-frozen Plasmas for Assignment of the International Normalized Ratio
1999 StandoutNobel
The Fate of Prothrombin and Factors VIII, IX and X Transfused to Patients Deficient in these Factors
1963
Antithrombin III, Antifactor Xa and Heparin
1970
FACTOR-VIII CONSUMPTION IN PRE-ECLAMPSIA
1977
Influence of Three Types of Automated Coagulometers on the International Sensitivity Index (ISI) of Rabbit, Human, and Recombinant Human Tissue Factor Preparations
1999 StandoutNobel
The Mode of Action of Antibodies which Destroy Factor VIII
1972
Thrombin and the Interaction of Factors VIII and IX
1965
The Specific Assay of Prothrombin Using the Taipan Snake Venom
1971